The US market for Hemostats and Sealants resumed its growth in Q121 as procedures climbed back towards normal.
While surgical procedures have not fully regained their pre-COVID levels, the US Hemostats and Sealants market grew in Q121 according to SmartTRAK Financial Dashboard. However, it continued to be a tale of two recoveries. CryoLife* and especially JNJ/Ethicon* posted solid gains for the quarter. However, as elective procedures continue to be behind pre-COVID levels, other manufacturers lagged by comparison.
- Complete Hemostats & Sealants Market Overview
- SmartTRAK's Expert Analysis and Insights
- US Hemostats and Sealants Market Resumes Growth
- Hemostats Have Balanced Recovery
- Sealants Lag Behind
- Important Q121 Market Events
JNJ/Ethicon pulled ahead in the US Hemostats and Sealants market in Q121 as it continued to use its presence to lead the way back into hospitals, while second-place Baxter* saw its YoY decline. A large part of that difference was driven by ...
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the top 15 Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, we transform the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost. To learn more about SmartTRAK, click here.
